Venetoclax
Brand name: Venclexta
Rank #73 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$259.6M
Total Cost
28,191
Total Claims
$259.6M
Total Cost
1,181
Prescribers
$9,207
Cost per Claim
1,956
Beneficiaries
28,416
30-Day Fills
$220K
Avg Cost/Provider
24
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$259.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $259.6M total
🔎 Data Overview
At $9,207 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $219,777 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $132,698 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Venetoclax
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Leslie Rudolph | Physician Assistant | New York, NY | 134 | $1.9M |
| 2 | Brian Hill | Hematology-Oncology | Cleveland, OH | 127 | $1.8M |
| 3 | Joshua Zeidner | Hematology-Oncology | Chapel Hill, NC | 163 | $1.6M |
| 4 | Erin Pettijohn | Hematology-Oncology | Grand Rapids, MI | 129 | $1.3M |
| 5 | Jennifer Tran | Nurse Practitioner | Houston, TX | 96 | $1.2M |
| 6 | Latha Sree Polavaram | Hematology-Oncology | Grand Rapids, MI | 123 | $1.1M |
| 7 | Carrie Englert | Nurse Practitioner | Overland Park, KS | 79 | $1.1M |
| 8 | Maria Dela Rosa | Nurse Practitioner | Duarte, CA | 85 | $1.1M |
| 9 | Ian Flinn | Hematology-Oncology | Nashville, TN | 103 | $1.1M |
| 10 | Adam Kittai | Hematology | New York, NY | 76 | $1.0M |
| 11 | Sunitha Vemulapalli | Hematology-Oncology | Canton, OH | 58 | $1.0M |
| 12 | Teresa Fogaren | Nurse Practitioner | Boston, MA | 73 | $1.0M |
| 13 | David Benton | Hematology-Oncology | Topsham, ME | 62 | $993K |
| 14 | Alexis Cruz-Chacon | Hematology-Oncology | San Juan, PR | 69 | $959K |
| 15 | John Winters | Hematology-Oncology | Scarborough, ME | 69 | $933K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 70 | Immune Globul G/Gly/Iga Avg 46 (Gamunex-C) | $266.5M | 27,501 |
| 71 | Rosuvastatin Calcium (Rosuvastatin Calcium) | $264.9M | 11,259,701 |
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
| 75 | Metoprolol Succinate (Metoprolol Succinate) | $256.3M | 12,847,535 |
| 76 | Dolutegravir Sodium (Tivicay) | $251.7M | 102,995 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology